Your mission
Adragos Athens (member of Adragos Pharma) is an innovative contract development company based in Europe. Our primary focus is to provide high-quality research for the development of generic and generic-plus products. Adragos Athens is seeking to hire a Formulation Technician who will accommodate a wide range of R&D activities pertaining to the formulation, process development and technology transfer of drug products. The R&D Formulation Technician will be expected to operate within a competent team of scientists and will report to the Formulation Senior Manager.
Key Responsibilities:
- Collaborate with Formulation Senior Manager in designing and conducting formulation process development studies for solid, liquid, and semi-solid dosage forms.
- Prepare and compound pharmaceutical formulations following established procedures and recipes.
- Assist in the development and optimization of formulation processes for solid, liquid, and semi-solid dosage forms. Support in the preparation and execution of stability studies.
- Conduct routine testing and analysis of formulations, including physical and chemical characterization.
- Ensuring maintenance of all formulation laboratory resources and equipment.
- Document and report results of all experiments.
- Participate in technology transfer activities, including the transfer of formulation processes and knowledge from the research and development stage to manufacturing.
- Collaborate with formulation scientists and other team members to troubleshoot and resolve formulation-related issues.
About us
Adragos Pharma is a reliable Contract Development and Manufacturing Organization (CDMO) headquartered in Munich, Germany. We provide comprehensive development and manufacturing services for drug products, including sterile and non-sterile liquids, solids, and semi-solids. Our expertise also covers biologicals, orphan drugs, clinical trials, fill-and-finish, and lyophilization, offering end-to-end solutions from product development to commercial supply.
With production sites in Germany, France, Greece, Norway, Japan, and Switzerland, we ensure high-quality manufacturing across all stages of the drug development process.
Founded in 2020, Adragos Pharma has rapidly grown through an ambitious buy & build strategy, supported by FSN Capital. With a team of over 900 professionals, we are expanding our operations across Europe, North America, and Japan to become a global leader in the CDMO sector.
As a key player in the pharmaceutical industry, CDMOs like Adragos produce 25% of all drugs globally, ensuring access to essential medications. With increasing healthcare demands, we continue to innovate and set new standards in drug manufacturing.
You want to be part of our dynamic growth? Then apply now!